Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000470631 | SCV000557815 | benign | Primary dilated cardiomyopathy | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528345 | SCV000723052 | likely benign | not provided | 2021-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619845 | SCV000736148 | likely benign | Cardiovascular phenotype | 2017-03-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001528345 | SCV004152125 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | TXNRD2: BP4, BP7 |
Diagnostic Laboratory, |
RCV001528345 | SCV001739948 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528345 | SCV001970598 | likely benign | not provided | no assertion criteria provided | clinical testing |